TWO SIGMA INVESTMENTS, LP
Position in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 1179392
NEW YORK, NY
Position in ZNTL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,670,939
+$7,752,669 QoQ
Shares Held
3,024,936
+2.3% QoQ
Ownership
4.22%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4
of 114 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. ZNTL ranks #69 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in ZNTL
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,670,939 | 3,024,936 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,918,270 | 2,956,526 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,986,408 | 1,471,414 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,058,653 | 1,363,347 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,267,941 | 1,093,053 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $873,441 | 549,334 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,868,904 | 616,800 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,343,651 | 908,601 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,304,307 | 1,052,398 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,861,121 | 244,995 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $2,195,145 | 109,429 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $471,107 | 16,700 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $4,360,322 | 94,502 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,189,701 | 14,153 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $10,594,160 | 158,976 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,855,937 | 128,871 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $2,962,190 | 57,031 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||